Publications by authors named "Foo Yoke Ching"

Claim this Profile
O
Oncologist-led counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomes.
Sook-Yee Yoon, Siu Wan Wong, Joanna Lim, Syuhada Ahmad, Shivaani Mariapun, Yoke Ching Foo

J Med Genet· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study.
Gwo-Fuang Ho, Chee-Shee Chai, Adlinda Alip, Mohd Ibrahim A Wahid, Matin Mellor Abdullah, Yoke-Ching Foo

BMC Cancer· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective Analysis of Cancer Care Performance and Survival Outcome for Nasopharyngeal Carcinoma at a leading Cancer Treatment Centre in Malaysia 2008-2012.
Matin Mellor Abdullah, Yoke Ching Foo, Beng Khiong Yap, Catherine May Ling Lee, L P Hoo

Asian Pac J Cancer Prev· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of HER2 Positivity and Its Clinicopathological Correlation in Locally Advanced/Metastatic Gastric Cancer Patients in Malaysia.
Pathmanathan Rajadurai, Ho Kean Fatt, Foo Yoke Ching

J Gastrointest Cancer· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast Cancer Survival at a Leading Cancer Centre in Malaysia.
Matin Mellor Abdullah, Ahmad Kamal Mohamed, Yoke Ching Foo, Catherine May Ling Lee, Chin Teong Chua

Asian Pac J Cancer Prev· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Four-Jointed Box 1 (FJX1)-Specific Peptides for Immunotherapy of Nasopharyngeal Carcinoma.
San Jiun Chai, Yoke Yeow Yap, Yoke Ching Foo, Lee Fah Yap, Sathibalan Ponniah, Sok Ching Cheong

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gefitinib as first line therapy in Malaysian patients with mutation-positive non-small-cell lung cancer: A single-center retrospective study.
Matin Mellor Abdullah, Amit Bhat, Ahmad Kamal Mohamed, Foo Yoke Ching, Nida Ahmed

Oncol Lett· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis